MedTrace Logo

Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block

NCT05556889 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2024-05-31

No results posted yet for this study

Summary

1. Efficacy of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy
2. Safety of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy

Conditions

  • Safety and Efficacy
  • Scalp Nerve Block

Interventions

PROCEDURE

a modified auriculotemporal nerve blockade

Helix feet in front of the zygomatic arch is served as anatomy marks of auriculotemporal nerve block, and the modified auriculotemporal nerve blockade is implemented as follows: Zygomatic arch level, posterior to the superficial temporal artery, the vertical puncture depth is about 0.5 -1 cm, and 2 ml of local anesthetics are injected after withdrawing without blood.

PROCEDURE

Traditional auriculotemporal nerve blockade

Traditional auriculotemporal nerve blockade

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • feng gao · professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05556889 on ClinicalTrials.gov